Skip to menu Skip to content Skip to footer

2025

Journal Article

Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine‐induced adverse effects in an acute lymphoblastic leukemia patient‐derived xenograft model

Starobova, Hana, McCalmont, Hannah, Shatunova, Svetlana, Tay, Nicolette, Smith, Christopher M., Robertson, Avril, Winkler, Ingrid, Lock, Richard B. and Vetter, Irina (2025). Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine‐induced adverse effects in an acute lymphoblastic leukemia patient‐derived xenograft model. HemaSphere, 9 (3) e70092, 3. doi: 10.1002/hem3.70092

Inhibition of the NLRP3 inflammasome using MCC950 reduces vincristine‐induced adverse effects in an acute lymphoblastic leukemia patient‐derived xenograft model

2025

Journal Article

A comprehensive protocol for simplified mouse DRG fixation, processing and F4/80 immunohistochemistry: Overcoming common challenges

Tay, Nicolette, Alshammari, Ammar, Kaur, Simranpreet, Pettit, Allison, Mu, Erica, Reid, Anna, Winkler, Ingrid, Vetter, Irina and Starobova, Hana (2025). A comprehensive protocol for simplified mouse DRG fixation, processing and F4/80 immunohistochemistry: Overcoming common challenges. Journal of Neuroscience Methods, 418 110434, 110434. doi: 10.1016/j.jneumeth.2025.110434

A comprehensive protocol for simplified mouse DRG fixation, processing and F4/80 immunohistochemistry: Overcoming common challenges

2024

Conference Publication

Antibody drug conjugate (ADC) payload-induced IL1 suggests potential for anti-IL1RAP therapy combination for enhanced treatment efficacy and prevention of neuropathy

Gyllenback, Elin Jaensson, Shatunova, Svetlana, Rydberg-Millrud, Camilla, Grönberg, Caitríona, Vetter, Irina, Starobova, Hana and Liberg, David (2024). Antibody drug conjugate (ADC) payload-induced IL1 suggests potential for anti-IL1RAP therapy combination for enhanced treatment efficacy and prevention of neuropathy. SITC 39th Annual Meeting (SITC 2024), Houston, TX United States, 6-10 November 2024. London, United Kingdom: BMJ Group. doi: 10.1136/jitc-2024-sitc2024.1303

Antibody drug conjugate (ADC) payload-induced IL1 suggests potential for anti-IL1RAP therapy combination for enhanced treatment efficacy and prevention of neuropathy

2024

Journal Article

The role of the neuronal microenvironment in sensory function and pain pathophysiology

Starobova, Hana, Alshammari, Ammar, Winkler, Ingrid G. and Vetter, Irina (2024). The role of the neuronal microenvironment in sensory function and pain pathophysiology. Journal of Neurochemistry, 168 (11), 3620-3643. doi: 10.1111/jnc.15724

The role of the neuronal microenvironment in sensory function and pain pathophysiology

2024

Journal Article

The role of the gut microbiome in neuroinflammation and chemotherapy-induced peripheral neuropathy

Shatunova, Svetlana, Aktar, Rubina, Peiris, Madusha, Lee, Jia Yu Peppermint, Vetter, Irina and Starobova, Hana (2024). The role of the gut microbiome in neuroinflammation and chemotherapy-induced peripheral neuropathy. European Journal of Pharmacology, 979 176818, 1-16. doi: 10.1016/j.ejphar.2024.176818

The role of the gut microbiome in neuroinflammation and chemotherapy-induced peripheral neuropathy

2024

Conference Publication

Impact on chemotherapy induced peripheral neuropathy of nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in patients with pancreatic cancer, with supportive mouse model data

Van Cutsem, Eric, Ochsenreither, Sebastian, Collignon, Joelle, Eefsen, Rikke Lovendahl, Ivanauskas, Audrius, Shatunova, Svetlana, Vetter, Irina, Gyllenback, Elin Jaensson, Skoog, Petter, Losic, Nedjad, Tersago, Dominique and Starobova, Hana (2024). Impact on chemotherapy induced peripheral neuropathy of nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in patients with pancreatic cancer, with supportive mouse model data. 2024 ASCO Annual Meeting Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary, Chicago, IL, United States, 31 May - 4 June 2024. Alexandria, VA, United States: American Society of Clinical Oncology.

Impact on chemotherapy induced peripheral neuropathy of nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in patients with pancreatic cancer, with supportive mouse model data

2024

Conference Publication

Impact on chemotherapy induced peripheral neuropathy of nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in patients with pancreatic cancer, with supportive mouse model data

Van Cutsem, Eric, Ochsenreither, Sebastian, Collignon, Joelle, Eefsen, Rikke Løvendahl, Ivanauskas, Audrius, Shatunova, Svetlana, Vetter, Irina, Gyllenbäck, Elin Jaensson, Skoog, Petter, Losic, Nedjad, Tersago, Dominique and Starobova, Hana (2024). Impact on chemotherapy induced peripheral neuropathy of nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in patients with pancreatic cancer, with supportive mouse model data. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/jco.2024.42.16_suppl.4148

Impact on chemotherapy induced peripheral neuropathy of nadunolimab, a first-in-class monoclonal antibody against IL1RAP, in patients with pancreatic cancer, with supportive mouse model data

2022

Journal Article

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients

Tay, Nicolette, Laakso, E-Liisa, Schweitzer, Daniel, Endersby, Raelene, Vetter, Irina and Starobova, Hana (2022). Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients. Frontiers in Molecular Biosciences, 9 1015746, 1015746. doi: 10.3389/fmolb.2022.1015746

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients

2022

Journal Article

A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling

Stables, Jennifer, Green, Emma K., Sehgal, Anuj, Patkar, Omkar L., Keshvari, Sahar, Taylor, Isis, Ashcroft, Maisie E., Grabert, Kathleen, Wollscheid-Lengeling, Evi, Szymkowiak, Stefan, McColl, Barry W., Adamson, Antony, Humphreys, Neil E., Mueller, Werner, Starobova, Hana, Vetter, Irina, Shabestari, Sepideh Kiani, Blurton-Jones, Matthew M., Summers, Kim M., Irvine, Katharine M., Pridans, Clare and Hume, David A. (2022). A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling. Development, 149 (8) dev200237. doi: 10.1242/dev.200237

A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling

2022

Journal Article

A peptide toxin in ant venom mimics vertebrate EGF-like hormones to cause long-lasting hypersensitivity in mammals

Eagles, David A., Saez, Natalie J., Krishnarjuna, Bankala, Bradford, Julia J., Chin, Yanni K.-Y., Starobova, Hana, Mueller, Alexander, Reichelt, Melissa E., Undheim, Eivind A. B., Norton, Raymond S., Thomas, Walter G., Vetter, Irina, King, Glenn F. and Robinson, Samuel D. (2022). A peptide toxin in ant venom mimics vertebrate EGF-like hormones to cause long-lasting hypersensitivity in mammals. Proceedings of the National Academy of Sciences, 119 (7) e2112630119. doi: 10.1073/pnas.2112630119

A peptide toxin in ant venom mimics vertebrate EGF-like hormones to cause long-lasting hypersensitivity in mammals

2022

Journal Article

Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider

Finol-Urdaneta, Rocio K., Ziegman, Rebekah, Dekan, Zoltan, McArthur, Jeffrey R., Heitmann, Stewart, Luna-Ramirez, Karen, Tae, Han-Shen, Mueller, Alexander, Starobova, Hana, Chin, Yanni K.-Y., Wingerd, Joshua S., Undheim, Eivind A. B., Cristofori-Armstrong, Ben, Hill, Adam P., Herzig, Volker, King, Glenn F., Vetter, Irina, Rash, Lachlan D., Adams, David J. and Alewood, Paul F. (2022). Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider. Proceedings of the National Academy of Sciences, 119 (5) e2110932119. doi: 10.1073/pnas.2110932119

Multitarget nociceptor sensitization by a promiscuous peptide from the venom of the King Baboon spider

2021

Journal Article

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release

Starobova, Hana, Monteleone, Mercedes, Adolphe, Christelle, Batoon, Lena, Sandrock, Cheyenne J., Tay, Bryan, Deuis, Jennifer R., Smith, Alexandra V., Mueller, Alexander, Nadar, Evelyn Israel, Lawrence, Grace Pamo, Mayor, Amanda, Tolson, Elissa, Levesque, Jean-Pierre, Pettit, Allison R., Wainwright, Brandon J., Schroder, Kate and Vetter, Irina (2021). Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release. Journal of Experimental Medicine, 218 (5) e20201452. doi: 10.1084/jem.20201452

Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1β release

2021

Conference Publication

Subcutaneous analgesic actions and mode of action of binding of ω-conotoxins at Cav2.2

Hasan, Mahadhi, Abraham, Nikita, Cardoso, Fernanda C., Ragnarsson, Lotten, Starobova, Hana, Mueller, Alexander, Vetter, Irina and Lewis, Richard J. (2021). Subcutaneous analgesic actions and mode of action of binding of ω-conotoxins at Cav2.2. Venom to Drugs, Daydream Island, QLD Australia, 15 - 19 March 2021.

Subcutaneous analgesic actions and mode of action of binding of ω-conotoxins at Cav2.2

2021

Journal Article

Subcutaneous ω-conotoxins alleviate mechanical pain in rodent models of acute peripheral neuropathy

Hasan, Md. Mahadhi, Starobova, Hana, Mueller, Alexander, Vetter, Irina and Lewis, Richard J. (2021). Subcutaneous ω-conotoxins alleviate mechanical pain in rodent models of acute peripheral neuropathy. Marine Drugs, 19 (2) 106, 1-15. doi: 10.3390/md19020106

Subcutaneous ω-conotoxins alleviate mechanical pain in rodent models of acute peripheral neuropathy

2021

Journal Article

Small cyclic sodium channel inhibitors

Peigneur, Steve, da Costa Oliveira, Cristina, de Sousa Fonseca, Flávia Cristina, McMahon, Kirsten L., Mueller, Alexander, Cheneval, Olivier, Cristina Nogueira Freitas, Ana, Starobova, Hana, Dimitri Gama Duarte, Igor, Craik, David J., Vetter, Irina, de Lima, Maria Elena, Schroeder, Christina I. and Tytgat, Jan (2021). Small cyclic sodium channel inhibitors. Biochemical Pharmacology, 183 114291, 114291. doi: 10.1016/j.bcp.2020.114291

Small cyclic sodium channel inhibitors

2020

Journal Article

The NLRP3 inflammasome: role and therapeutic potential in pain treatment

Starobova, Hana, Nadar, Evelyn Israel and Vetter, Irina (2020). The NLRP3 inflammasome: role and therapeutic potential in pain treatment. Frontiers in Physiology, 11 1016, 1016. doi: 10.3389/fphys.2020.01016

The NLRP3 inflammasome: role and therapeutic potential in pain treatment

2020

Other Outputs

Novel therapeutic targets for the treatment of vincristine induced peripheral neuropathy

Starobova, Hana (2020). Novel therapeutic targets for the treatment of vincristine induced peripheral neuropathy. PhD Thesis, Institute for Molecular Bioscience, The University of Queensland. doi: 10.14264/uql.2020.972

Novel therapeutic targets for the treatment of vincristine induced peripheral neuropathy

2020

Journal Article

Mapping the molecular surface of the analgesic NaV1.7-selective peptide Pn3a reveals residues essential for membrane and channel interactions

Mueller, Alexander, Dekan, Zoltan, Kaas, Quentin, Agwa, Akello J., Starobova, Hana, Alewood, Paul F., Schroeder, Christina I., Mobli, Mehdi, Deuis, Jennifer R. and Vetter, Irina (2020). Mapping the molecular surface of the analgesic NaV1.7-selective peptide Pn3a reveals residues essential for membrane and channel interactions. ACS Pharmacology and Translational Science. doi: 10.1021/acsptsci.0c00002

Mapping the molecular surface of the analgesic NaV1.7-selective peptide Pn3a reveals residues essential for membrane and channel interactions

2019

Journal Article

Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen

Mueller, Alexander, Starobova, Hana, Morgan, Michael, Dekan, Zoltan, Cheneval, Olivier, Schroeder, Christina I., Alewood, Paul F., Deuis, Jennifer R. and Vetter, Irina (2019). Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen. Pain, 160 (8), 1766-1780. doi: 10.1097/j.pain.0000000000001567

Antiallodynic effects of the selective NaV1.7 inhibitor Pn3a in a mouse model of acute postsurgical pain: evidence for analgesic synergy with opioids and baclofen

2019

Journal Article

Minocycline prevents the development of mechanical allodynia in mouse models of vincristine-induced peripheral neuropathy

Starobova, H., Mueller, A., Allavena, R., Lohman, R. J., Sweet, M. J. and Vetter, I. (2019). Minocycline prevents the development of mechanical allodynia in mouse models of vincristine-induced peripheral neuropathy. Frontiers in Neuroscience, 13 (JUN) 653, 653. doi: 10.3389/fnins.2019.00653

Minocycline prevents the development of mechanical allodynia in mouse models of vincristine-induced peripheral neuropathy